[METRIC]
A-A-53621A
18 December 1992
SUPERSEDING
A-A-0053621 (DM)
26 August 1988
COMMERCIAL ITEM DESCRIPTION
CEPHRADINE FOR ORAL SUSPESION, USP
The General Services Administration has authorized the use of this Commercial Item Description.
Salient characteristics.
Shall be Cephradine for Oral Suspension, USP.
All ingredients shall be of a pharmaceutical grade.
Each bottle shall contain a quantity of dry mixture equivalent to 2.5 g of Cephradine within the applicable assay limits.
When reconstituted to 100 ml, 5 ml of solution shall contain 125 mg of Cephradine within the applicable assay limits.
Workmanship. The suspension shall be free from defects which detract from its appearance or impair its serviceability.
Unit. Bottle (BT). Shall be supplied in a commercially available bottle with a child resistant safety closure, and sufficient capacity to hold 100 ml with adequate shake space. One bottle, as specified, constitutes one unit.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business